RedHill Biopharma, IntelGenx Provide Update on FDA's Ongoing Review of NDA for RHB-103 Oral Migraine Film
April 24, 2014 at 08:06 AM EDT
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill"), an emerging Israeli biopharmaceutical company focused primarily on the development ...